XWELL, Inc. to Report Third Quarter 2024 Results on Thursday, November 14, 2024
- NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced that it will report third quarter 2024 financial results, on Thursday, November 14, 2024, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.
- 11/12/2024
|
ThredUp And 2 Other Stocks Under $2 Executives Are Buying
- The Dow Jones index closed higher by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
- 09/16/2024
|
XWELL Appoints Ezra Ernst as New President and Chief Executive Officer
- Strategic leadership change will drive further growth and expansion among core business units Strategic leadership change will drive further growth and expansion among core business units
- 09/05/2024
|
XWELL Announces Partnership with Priority Pass
- Partnership will bring growth opportunities and expands XpresSpa's brand to more travelers Partnership will bring growth opportunities and expands XpresSpa's brand to more travelers
- 08/26/2024
|
XWELL, Inc. Adopts Tax Benefits Preservation Plan
- NEW YORK, Aug. 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (the “Company”) announced today that its Board of Directors has adopted a Tax Benefits Preservation Plan (the “Plan”) intended to preserve the value of certain of the Company's tax attributes related to previously recorded net operating losses (the “Tax Attributes”).
- 08/16/2024
|
XWELL, Inc. Reports Second Quarter 2024 Results
- NEW YORK, Aug. 14, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the second quarter ended June 30, 2024.
- 08/14/2024
|
XWELL Comments on CPC's Withdrawal of Threatened Proxy Fight and Related Lawsuit
- NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today issued the following statement in response to CPC Pain & Wellness SPV, LLC's (“CPC”) decision to withdraw its threatened proxy fight and related lawsuit against XWELL, in connection with the Company's 2024 annual meeting of stockholders (the “2024 Annual Meeting”).
- 08/13/2024
|
XWELL Announces Closing of $1.4 Million Registered Direct Offering Priced At Premium to Market
- NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced the closing of its previously announced registered direct offering priced at a premium to market for the issuance and sale of an aggregate of 652,705 shares of its common stock, par value $0.01 per share, at a purchase price of $2.18 per share.
- 08/08/2024
|
CPC Issues Letter to Fellow XWELL, Inc. Shareholders Revealing Intention Behind Recent Schedule 13D Filing & Lawsuit Against Entrenched Board of Directors
- NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Today, CPC Pain & Wellness SPV, LLC (“CPC”), a significant XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”) shareholder that beneficially owns 394,200 or 9.42% of XWELL's outstanding shares, issued the below letter to its fellow shareholders. The letter informs shareholders of CPC's recent lawsuit filing against the incumbent members of XWELL's Board of Directors for breach of their fiduciary duties and for the Board's wrongful and inequitable efforts to prevent CPC from nominating a competing slate of directors and consequently denying shareholders the opportunity to choose who they elect to XWELL's Board at the upcoming annual shareholder meeting. In its letter, CPC details how current Board members have personally benefited from XWELL while overseeing an astounding decline in XWELL shareholder value and substantial net losses. CPC also shares in the below letter its vision for restoring and maximizing shareholder value.
- 07/24/2024
|
XWELL Announces Director Candidate Nomination Notice Submitted by CPC is Invalid
- NEW YORK--(BUSINESS WIRE)--XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced that the notice materials submitted by CPC Pain & Wellness SPV, LLC (“CPC”), which purported to provide notice of CPC's intent to nominate four candidates for election to the Company's five-member Board of Directors (the “Board”) at the 2024 Annual Meeting of Stockholders, is invalid. CPC, a special purpose vehicle that was recently forme.
- 07/22/2024
|
XWELL Opens New XpresSpa Location at Philadelphia International Airport
- New location expands domestic footprint in busy Northeast corridor with labor lite tech forward service offerings New location expands domestic footprint in busy Northeast corridor with labor lite tech forward service offerings
- 06/17/2024
|
XWELL Continues to Innovate in Airport Wellness Space with New Massage Solutions: Introducing Ceragem V6 in select XpresSpa® Locations in US
- Expanded service offering underscores XWELL's ongoing focus on delivering cost-effective wellness services that drive top-line growth Expanded service offering underscores XWELL's ongoing focus on delivering cost-effective wellness services that drive top-line growth
- 05/23/2024
|
XWELL, Inc. Reports First Quarter 2024 Results
- NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the first quarter ended March 31, 2024.
- 05/15/2024
|
XpresSpa Introduces IV Hydration Drip Therapy at Miami International Airport
- Pilot program designed to expand service offerings and drive revenue growth Pilot program designed to expand service offerings and drive revenue growth
- 05/02/2024
|
XWELL, Inc. (XWEL) Q4 2023 Earnings Call Transcript
- XWELL, Inc. (XWEL) Q4 2023 Earnings Call Transcript
- 04/16/2024
|
XWELL, Inc. Reports Fiscal Year 2023 Results
- NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the year ended December 31, 2023.
- 04/16/2024
|
XWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, April 16, 2024
- NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced that it will report results for the year ended December 31, 2023, on Tuesday, April 16, 2024, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.
- 04/16/2024
|
XWELL, Inc. Plans to File Form 12b-25 to Extend Filing Date of its Form 10-K
- NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced plans to file a Form 12b-25 with the U.S. Securities and Exchange Commission regarding its Annual Report on Form 10-K for the year ended December 31, 2023. Additional time is needed for the Company to compile and analyze supporting documentation in order to finalize the Form 10-K and in order to permit the Company's independent registered public accounting firm to complete its audit of the consolidated financial statements included in the Form 10-K. The Company currently anticipates filing the Form 10-K as soon as practicable.
- 04/01/2024
|
CDC Traveler-based Genomic Surveillance Program to Expand to Two New US International Airports in Miami and Chicago
- The TGS program, a leading example of biosecurity infrastructure, operates at a total of nine US locations and leverages voluntary nasal swabs as well as wastewater sampling from international travelers to detect more than 30 pathogens. BOSTON, March 12, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, the Centers for Disease Control and Prevention (CDC), and XpresCheck, by XWELL, Inc. (Nasdaq: XWEL), a leader in the delivery of onsite pathogen screening, today announced they are expanding the CDC's Traveler-based Genomic Surveillance program (TGS) to new collection locations at US international airports in Miami (MIA) and Chicago (ORD).
- 03/12/2024
|
XWELL Appoints Veteran Consumer & Wellness Entrepreneur Gaëlle Wizenberg to its Board of Directors
- NEW YORK, Dec. 15, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced the appointment of Gaëlle Wizenberg to the Company's Board of Directors, effective January 1, 2024. The Company also announced that Donald Stout, who joined XWELL's Board of Directors in 2012, will be retiring from his position.
- 12/15/2023
|
XWELL Opens New XpresSpa Location in Abu Dhabi International Airport
- Eleventh international wellness center is the latest move by XWELL to expand its global footprint Eleventh international wellness center is the latest move by XWELL to expand its global footprint
- 11/15/2023
|
XWELL, Inc. Reports Third Quarter 2023 Results
- Airport Spas Deliver Strong 39% Year-Over-Year Q3 Revenue Growth Naples Wax Center Acquisition Accelerates Future Off-Airport Growth Opportunities Further Airport Spa Expansion Internationally
- 11/14/2023
|
Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens
- The program can be an effective early warning system for public health and national security officials, leveraging voluntary nasal and wastewater sampling from international travelers at major U.S. airports BOSTON , Nov. 6, 2023 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and XWELL, Inc. (Nasdaq: XWEL) today announced they are expanding their work with the U.S. Centers for Disease Control and Prevention's (CDC's) Traveler-based Genomic Surveillance program (TGS) to test for more than 30 additional priority pathogens, in addition to SARS-CoV-2. TGS is a flexible, multimodal platform that consists of three complementary approaches of sample collection from arriving international travelers at U.S. airports, including voluntary nasal swabbing, aircraft wastewater, and airport wastewater sampling to enhance early detection of new SARS-CoV-2 variants and other pathogens, and fills gaps in global surveillance.
- 11/06/2023
|
XWELL's CEO Scott Milford Discusses Strategic Growth Plans During Recent Investor Fireside Chat
- Highlights the Recent Acquisition of Naples Wax Center as Launch Pad for XWELL's Out of Airport Strategy Highlights the Recent Acquisition of Naples Wax Center as Launch Pad for XWELL's Out of Airport Strategy
- 10/09/2023
|
XWELL Celebrates Breast Cancer Awareness Month with Philanthropic Nail Care Program
- Proceeds from select XpresSpa nail care services to be donated to Susan G. Komen Proceeds from select XpresSpa nail care services to be donated to Susan G. Komen
- 10/02/2023
|
XWELL's CEO Scheduled to Present at Upcoming Investor Fireside Chat on October 4, 2023
- Scott Milford to Present at Water Tower Research Fireside Chat Series on Wednesday, October 4, 2023, at 2:30 p.m. E.T. Scott Milford to Present at Water Tower Research Fireside Chat Series on Wednesday, October 4, 2023, at 2:30 p.m. E.T.
- 09/28/2023
|
XWELL, Inc. Announces 1-for-20 Reverse Stock Split
- NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL), announced today that it will effect a 1-for-20 reverse stock split of its common stock effective at 5:00 pm Eastern Time on Wednesday, September 27, 2023. Shares of XWELL's common stock are expected to begin trading on a split-adjusted basis when markets open on Thursday, September 28, 2023.
- 09/27/2023
|
XWELL Introduces New Stretch Service at XpresSpa
- NEW YORK, Sept. 19, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, continues to evolve its service offerings with the introduction of a proprietary stretching service for XpresSpa locations nationally.
- 09/19/2023
|
XWELL Grows Footprint Outside the Airport with Acquisition of Naples Wax Center
- Transaction represents the first step in building XWELL's retail portfolio outside the airport and positions the Company for revenue growth and profitability Transaction represents the first step in building XWELL's retail portfolio outside the airport and positions the Company for revenue growth and profitability
- 09/12/2023
|
XWELL, Inc. (XWEL) Q2 2023 Earnings Call Transcript
- XWELL, Inc. (NASDAQ:XWEL ) Q2 2023 Results Conference Call August 14, 2023 5:00 PM ET Company Participants Suzanne Scrabis - CFO Scott Milford - CEO Operator Greetings. Welcome to XWELL's Second Quarter 2023 Earnings Conference Call.
- 08/17/2023
|
XWELL Extends Collaboration with Centers for Disease Control and Prevention's Traveler-Based Genomic Surveillance Program
- Since August 2021, the program has served as a critical monitoring system for biological threats, leveraging voluntary sampling from international travelers at major U.S. airports Since August 2021, the program has served as a critical monitoring system for biological threats, leveraging voluntary sampling from international travelers at major U.S. airports
- 08/17/2023
|
XWELL, Inc. to Announce Second Quarter 2023 Financial Results on Monday, August 14
- NEW YORK, Aug. 07, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today announced that it will release second quarter 2023 financial results on Monday, August 14, 2023, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.
- 08/07/2023
|
XWELL, Inc. to Announce First Quarter 2023 Financial Results on Monday, May 15
- NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today announced that it will release first quarter 2023 financial results on Monday, May 15, 2023, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.
- 05/11/2023
|
XWELL, Inc. to Announce 2022 Financial Results on Monday April 17
- NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in health and wellness solutions for people on the go, today announced that it will release fiscal year 2022 financial results on Monday, April 17, 2023, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.
- 04/14/2023
|
7 Penny Stocks That Actually Have Buy Ratings
- This article focuses on penny stocks with “buy” ratings from analysts. Analysts have access to information about companies that retail investors cannot obtain.
- 12/01/2022
|
XWELL, Inc. (XWEL) Q3 2022 Earnings Call Transcript
- XWELL, Inc. (NASDAQ:XWEL ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Omar Haynes - Interim CFO Scott Milford - CEO Operator Greetings, and welcome to XWELL's Third Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded on Thursday, November 10, 2020.
- 11/13/2022
|
XWELL, Inc. to Announce Third Quarter 2022 Financial Results on Thursday, November 10
- Webcast and Conference Call Scheduled for 4:30 PM ET Webcast and Conference Call Scheduled for 4:30 PM ET
- 11/03/2022
|